Key Highlights of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2025-2034: Growth Dynamics, Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Over the 2025–2034 Period?
In recent times, the market size for minimally invasive glaucoma surgery (MIGS) devices has seen considerable escalation. Its market value is anticipated to elevate from $0.7 billion in 2024 to $0.9 billion in 2025, reflecting a compound annual growth rate (CAGR) of 28.3%. Several factors have contributed to this increase during the historic period, including a heightened awareness around blindness prevention, substantial investment in healthcare infrastructure, enhanced patient understanding concerning advanced vision correction treatments, increased awareness for the same, and the advent of various government initiatives.
Forecasted to experience significant expansion, the market size for minimally invasive glaucoma surgery (MIGS) devices is predicted to reach a staggering $2.42 billion by 2029—this represents a compound annual growth rate (CAGR) of 28.1%. Predicted growth in this period is largely attributed to several factors such as, an increasing occurrence of eye conditions, particularly glaucoma, an aging population, better healthcare infrastructure, and a heightened need for more efficient and safer treatment methods. Other anticipated trends contributing to this forecasted growth include heightened adaptation and utilization of MIGS devices, technological advancements, production of innovatively designed MIGS devices, development of advanced implantable devices, and further progression in ophthalmic technology.
What Drivers Are Shaping the Growth of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The surge in eye ailment cases is anticipated to boost the expansion of the minimally invasive glaucoma surgery (MIGS) devices industry. These disorders cover a broad spectrum of issues that impact a person’s sight and eye health. Due to factors such as modifications in lifestyle, environmental factors, and aging demographics, the rate of such disorders is on the rise. MIGS devices serve as cutting-edge solutions for the treatment of different eye diseases, chiefly aiming at decreasing the intraocular pressure to curtail or manage the progression of glaucoma. As per the estimations by the National Eye Institute, a US governmental organization, by 2030, approximately 2.2 million US citizens are projected to suffer partial or total loss of sight in 2024. Consequently, the climbing rate of eye disorders acts as a driving force for the advancement of the minimally invasive glaucoma surgery (MIGS) devices market.
Request Your Free Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (MIGS) devices market are:
• AbbVie Inc._x000D_
• Novartis AG_x000D_
• Alcon Inc._x000D_
• Bausch Health Companies Inc._x000D_
• Bausch & Lomb Incorporated Inc._x000D_
Which Cutting-Edge Trends Are Expected to Drive the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market’s Growth?
Leading firms in the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the creation of novel products such as stent injectable systems. These developments aim to meet the unsolved issues in managing glaucoma and enhance patient results. A stent injectable system is a MIGS tool that utilizes an injection-like process to deliver and implant a small stent into the patient’s body using a specialized delivery mechanism commonly employed in minimally invasive procedures for diseases like obstructed or narrowed blood vessels. For example, in August 2022, Glaukos Corporation, an American ophthalmic medical technology firm, was granted 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the iStent Infinite Trabecular Micro-Bypass System. This novel three-stent injectable system, the iStent Infinite, is designed to provide a foundational, round-the-clock intraocular pressure (IOP) control for patients with primary open-angle glaucoma (POAG) who are not responding well to previous medication and surgical therapy.
Pre-order Your Report for Quick and Easy Delivery!
How Are the Key Segments of the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Driving Opportunities and Innovations?
The minimally invasive glaucoma surgery (MIGS) devices market covered in this report is segmented –
1) By Product: Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Other Products
2) By Surgery: Glaucoma In Conjunction With Cataract, Stand Alone Glaucoma
3) By Target: Trabecular Meshwork, Suprachoroidal Space, Other Targets
4) By Distribution Channel: Direct Tender, Retail Sales
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCS), Other End Users
Subsegments:
1) By Valves: Micro Shunt Valves, Non-penetrating Valves
2) By Glaucoma Drainage Implant: Scleral Drainage Implants, Subconjunctival Drainage Implants
3) By Glaucoma Tube Shunts: Ahmed Tube Shunt, Baerveldt Tube Shunt
4) By Stents: Ab-Interno Stents, Ab-Externo Stents
5) By Other Products: Cyclodestructive Devices, Trabecular Bypass Devices
Which Regions Are Most Influential in Expanding the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (MIGS) devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Categorized and Defined in the Industry?
Minimally invasive glaucoma surgery (MIGS) devices are medical instruments designed to lower intraocular pressure (IOP) in patients with glaucoma through less invasive surgical techniques compared to traditional glaucoma surgeries. These devices aim to reduce the risk of complications, shorten recovery time, and improve patient outcomes by offering a safer and less invasive option for patients needing surgical intervention to manage their condition.
Browse Through More Similar Reports By The Business Research Company:
Minimally Invasive Surgery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/minimally-invasive-surgery-global-market-report
Non-Invasive Ventilators Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/non-invasive-ventilators-global-market-report
Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
